April 27, 2024
Market Now
Samjin Pharma’s Q1 operating profit up 4.75% to W11.2b
[DISCLOSURE] Samjin Pharmaceuticals (005500) reported on April 26 that its operating profit in the first quarter increased 4.75 percent to 11.2 billion won (US$9.97 million) from the same period last year.
Revenue was up 3.25 percent to 60.1 billion won and net profit 6.70 percent to 8.6 billion won on-year.
By Hwang You-mee (theinvestor@heraldcorp.com)
Revenue was up 3.25 percent to 60.1 billion won and net profit 6.70 percent to 8.6 billion won on-year.
By Hwang You-mee (theinvestor@heraldcorp.com)
